Jiangsu ProteLight Pharmaceutical & Biotechnology Co., Ltd.

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Phase II Study to Evaluate Efficacy and Safety of AMP Peptide PL-5 in Mild Infections of Diabetic Foot Ulcers	Diabetes Complications, Diabetic Foot, Foot Ulcer, Infections, Leg Ulcer, Skin Ulcer, Skin and Connective Tissue Diseases, Wound Infection, cardiovascular disorder, diabetes mellitus, diabetic neuropathy, diabetic peripheral angiopathy, endocrine system disorder, skin disorder, vascular disorder	Active, not recruiting	Phase 2	2025-05-25		NCT06189638

Clinical trials